William David Wells-Gatnik (William Wells-Gatnik)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Congenital Heart Disease

Top Venues

Expert opinion on biological therapy

Expert review of neurotherapeutics

Expert opinion on drug safety

Pain management

This page only lists publications with an associated author ORCID identifier.

Publications

William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy 24 (5) (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy 24 (5) (2024)
William David Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine. Expert review of neurotherapeutics (2024)
William David Wells-Gatnik, Paolo Martelletti
Switching CGRP(r) MoAbs in migraine: what evidence? Expert opinion on biological therapy (2024)
William David Wells-Gatnik, Paolo Martelletti
Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal. Expert opinion on drug safety (2023)
William David Wells-Gatnik, Paolo Martelletti
Gepants in the acute management of migraine. Pain management (2023)